REQUEST A DEMO
Total
USD $0.00
Search more companies

3D Global Biotech Inc. (Taiwan, China)

Main Activities: Medical Equipment and Supplies Manufacturing
Full name: 3D Global Biotech Inc. Profile Updated: February 22, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Chinese Download a sample report

3D Global Biotech Inc. is a biotechnology company. The company aims to develop and produce customized autologous cell medical products, based on cell culture system, 3D printing technology and “Bio-inks” water glue. The company's main products are divided into two categories: soft tissue and hard tissue reconstruction medical products. The company was established in 2014 and is headquartered in New Taipei City, Taiwan.

Headquarters
21F.-3, No. 99, Sec. 1, Xintai 5Th Rd., Xizhi Dist
New Taipei City; New Taipei City;

Contact Details: Purchase the 3D Global Biotech Inc. report to view the information.

Website: http://www.3dglobalbiotech.com.tw

Basic Information
Total Employees:
Purchase the 3D Global Biotech Inc. report to view the information.
Outstanding Shares:
Purchase the 3D Global Biotech Inc. report to view the information.
Financial Auditors:
Purchase the 3D Global Biotech Inc. report to view the information.
Incorporation Date:
December 26, 2014
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
13.24%
Purchase this report to view the information.
0.89%
Purchase this report to view the information.
0.18%
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after 3D Global Biotech Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
43.66%
Total operating revenue
43.66%
Operating profit (EBIT)
6.62%
EBITDA
5.51%
Net Profit (Loss) for the Period
7.7%
Total assets
-15.98%
Total equity
-16.16%
Operating Profit Margin (ROS)
187.76%
Net Profit Margin
184.04%
Return on Equity (ROE)
-0.89%
Quick Ratio
-5.47%
Cash Ratio
-0.58%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?